NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000119

Registered date:07/09/2005

Gene evaluation for antihypertensive drug effects study

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedessential hypertension
Date of first enrollment2004/04/01
Target sample size300
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)thiazide diuretics indapamide calcium channel blocker amlodipine angiotensin II receptor blocker valsartan

Outcome(s)

Primary Outcomegene polymorphisms relating to blood pressure lowering effect of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker
Secondary Outcomegene polymorphisms relating to side effects of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriasevere hypertension (more than 180 and/or 110 mmHg) secondary hypertension female with pregnancy

Related Information

Contact

public contact
Name Kei Kamide
Address 5-7-1, Fujishirodai, Suita, Osaka 565-8565 Japan
Telephone 06-6833-5012
E-mail kamide@hsp.ncvc.go.jp
Affiliation National Cardiovascular Center Division of Hypertension and Nephrology
scientific contact
Name Yuhei Kawano
Address 5-7-1, Fujishirodai, Suita, Osaka 565-8565 Japan
Telephone 06-6833-5012
E-mail
Affiliation National Cardiovascular Center Division of Hypertension and Nephrology